Novanta (NOVT)
Search documents
Novanta (NOVT) - 2024 Q1 - Quarterly Results
2024-05-07 12:00
Exhibit 99.1 FOR IMMEDIATE RELEASE May 7, 2024 Novanta Announces Financial Results for the First Quarter 2024 • First Quarter 2024 GAAP Revenue of $231 million • First Quarter 2024 GAAP Net Income of $15 million • First Quarter 2024 GAAP Diluted Earnings Per Share of $0.41 • First Quarter 2024 Adjusted Earnings Per Share of $0.74 • First Quarter 2024 Adjusted EBITDA of $50 million BEDFORD, Mass., May 7, 2024 -- Novanta Inc. (Nasdaq: NOVT) (“Novanta” or the “Company”), a trusted technology partner to medical ...
Novanta (NOVT) - 2023 Q4 - Earnings Call Transcript
2024-02-28 20:52
In addition to all of this in 2023, we signed an agreement to acquire Motion Solutions which will enhance our portfolio and further expand our presence in the highly attractive medical and precision medicine space. We're happy to have completed the acquisition at the beginning of January 2024. Going into more detail, for the full year of 2023, sales to medical markets made up approximately 54% of total Novanta sales and grew 13% versus the prior year, driven by strong double-digit growth in minimally invasi ...
Novanta (NOVT) - 2023 Q4 - Annual Report
2024-02-28 14:30
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☑ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 (I.R.S. Employer Identification No.) (781) 266-5700 (Registrant's telephone number, including area code) Securities Registered Pursuant to Section 12(b) of the Act: | Title of each class | Trading Symbol(s ...
Novanta (NOVT) - 2023 Q4 - Annual Results
2024-02-28 13:00
Fourth Quarter FOR IMMEDIATE RELEASE February 28, 2024 Novanta Announces Financial Results for the Fourth Quarter and Full Year 2023 BEDFORD, Mass., February 28, 2024 -- Novanta Inc. (Nasdaq: NOVT) ("Novanta" or the "Company"), a trusted technology partner to medical and advanced technology equipment manufacturers, today reported financial results for the fourth quarter and full year 2023. | Financial Highlights | | | Three Months Ended December 31, | | | | Year Ended December 31, | | | --- | --- | --- | -- ...
Novanta (NOVT) - 2023 Q3 - Earnings Call Transcript
2023-11-07 21:23
Okay, thanks very much. Matthijs Glastra Thanks, Lee. Operator The next question comes from Brian Drab of William Blair. Please go ahead. Brian Drab Hi, thanks for taking the questions. Matthijs Glastra Hey. Good morning. Brian Drab Good morning. Robert, you said and I just kind of missed all the context, but you said acceleration in 2024 potentially. Can you just restate that and elaborate on the drivers that you're talking about at the moment? Robert Buckley Yes, so I would say regardless of how the marke ...
Novanta (NOVT) - 2023 Q2 - Earnings Call Transcript
2023-08-09 01:29
Company Participants Conference Call Participants Operator I would now like to turn the conference over to Ray Nash, Corporate Finance Leader for Novanta. Please go ahead. Thank you very much. Good morning, and welcome to Novanta's second quarter 2023 earnings conference call. I am Ray Nash, Corporate Finance Leader of Novanta. With me on today's call is our Chair and Chief Executive Officer, Matthijs Glastra; and our Chief Financial Officer, Robert Buckley. If you have not received a copy of our earnings p ...
Novanta (NOVT) - 2023 Q2 - Quarterly Report
2023-08-08 13:34
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2023 Or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No.: 001-35083 NOVANTA INC. (Exact name of registrant as specified in its charter) New Brunswick, Canada 98-0110412 (State or other jurisdiction of inc ...
Novanta (NOVT) - 2023 Q1 - Earnings Call Transcript
2023-05-14 10:12
Novanta Inc. (NASDAQ:NOVT) Q1 2023 Earnings Conference Call May 9, 2023 10:00 AM ET Company Participants Ray Nash - Corporate Finance Leader Matthijs Glastra - Chairman & Chief Executive Officer Robert Buckley - Chief Financial Officer Conference Call Participants Lee Jagoda - CJS Securities Brian Drab - William Blair Robert Mason - Baird Operator Good morning. My name is Andrea and I will be your conference operator today. At this time, I would like to welcome everyone to the Novanta Incorporated's 2023 Fi ...
Novanta (NOVT) - 2023 Q1 - Quarterly Report
2023-05-09 13:31
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2023 Or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No.: 001-35083 NOVANTA INC. (Exact name of registrant as specified in its charter) New Brunswick, Canada 98-0110412 (State or other jurisdiction of in ...
Novanta (NOVT) - 2022 Q4 - Earnings Call Transcript
2023-03-01 21:01
Novanta Inc. (NASDAQ:NOVT) Q4 2022 Results Conference Call March 1, 2023 10:00 AM ET Ray Nash - Corporate Finance Leader Matthijs Glastra - Chair and Chief Executive Officer Robert Buckley - Chief Financial Officer Lee Jagoda - CJS Securities Brian Drab - William Blair Joseph Donahue - Baird Good morning. My name is Keith, and I will be your conference operator today. At this time, I would like to welcome everyone to Novanta Inc. 2022 Fourth Quarter and Full Year Earnings Call. All lines have been placed on ...